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Introduction:
Sepsis, which is a deteriorating clinical outcome of a war between pathogens and host immune
response represents one of the major public health issues in neonates. (1,2) World Health
Organization (W.H.O) data from 2019 reports 6700 neonatal deaths per day and 75% of deaths
occur within the 1st week of life. (3) There are 2 clinical forms of neonatal sepsis which include
early-onset sepsis (EOS) (day 1 to day 7) and late-onset sepsis (LOS) (day 8 to day 28), they
vary in their clinical, microbiological features, and management plans. Although blood culture
is a well-established gold standard diagnostic method being implemented in the present clinical
setting, it takes 48 to 72 hrs to identify the microbial pathogens and is less sensitive in terms of
diagnosing true positive cases. Due to the rapid deterioration of true sepsis cases, instant broadspectrum antibiotic therapy is the only way to combat and control the infection in suspected
sepsis (4), but this empirical use has further challenged neonatologists in prescribing antibiotics
due to the emergence of antibiotic resistance among prevalent bacteria. Serum markers and
hematological indices are not efficient enough for the diagnosis of sepsis since these parameters
also rely on physiological changes due to several other factors. (5) Recently several studies
have been reported on epigenetic modifications of DNA as a predisposing factor for several
diseases among neonates and adults. Identification of specific differentially methylated genes
has been shown to serve as a promising marker for the diagnosis and predicting the prognosis
of sepsis in neonates. (6) Out of several putative genes, the gene encoding sepsis protein
markers in serum, CALCA gene (calcitonin-related polypeptide alpha) revealed altered DNA
methylation pattern in sepsis babies when compared to healthy controls. CpG (Cytosine
phosphodiester bond Guanine) sites in the promoter region of the CALCA gene are associated
with DNA methylation (7) which has been postulated to contain microbial infection-specific
response elements that are involved in transcriptional regulation of procalcitonin (PCT) during
bacterial sepsis. PCT is an acute-phase protein whose concentration increases in response to
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bacterial infection and a change in the methylation pattern of the CALCA gene could provide a
hallmark in finding appropriate epigenetic biomarkers in neonatal sepsis.
It is suggested from the above description that the promoter region of this gene with its
methylation pattern has great importance in sepsis. CALCA is a gene that codes for two
alternatively spliced products, calcitonin, and calcitonin gene-related peptide (α-CGRP), and
these are cleaved from larger pro-peptides PCT and proCGRP, respectively. This gene is
situated on chromosome 11 mainly consisting of six exons. Exon 1 is non-coding and exon 2
codes for the signal sequences. (8) PCT is released as an acute-phase protein from leukocytes
in response to the various cytokines or toxins of bacteria in the serum during infection. (8-11)
PCT levels are found to be raised to the maximum in cases of bacteremia and a moderate extent
in fungemia. (12) The level of the same fall as the infection is controlled suggesting a
correlation with the CALCA gene downregulation. (13) PCT kinetics are not significantly
affected by hemofiltration so can be used in practice to diagnose sepsis in those patients too.
(14,15) Its levels show a higher diagnostic significance than the other established markers for
sepsis (16,17), and unlike C-reactive protein (CRP) that is lowered on the administration of
glucocorticoids, PCT levels remain the same as long as the infection persists. (18) The
characteristic feature of differentiating systemic inflammation from infection improves the
overall significance of sepsis diagnosis. (19,20)
Objective
We aimed to study the DNA methylation status in the promoter region of the CALCA gene in
neonatal sepsis and compare it with normal healthy controls from a tertiary care centre in South
India.
Materials and Methods:
A prospective observational study was carried out with 115 neonates including clinically
suspected sepsis and normal healthy controls. The study was carried out in the Department of
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Biochemistry in collaboration with the Department of Pediatrics. Institutional ethical
committee clearance [letter no. JSSMC/IEC/3107/03 STS/2018-19] was obtained before the
commencement of the study and informed consent from the parents was taken before the
collection of blood samples.
Inclusion criteria:
The presence of two or more below-mentioned symptoms was taken as a case of
suspected/probable sepsis with or without accompanying bacteremia in the first 4 weeks of life.
The symptoms include:
● Lethargy or loss of consciousness, poor/stopped feeding, weak/stopped crying in a
previously normal baby, fever (Temp 37.5°C or more) or low body temp (< 35.5° C),
abdominal distension/vomiting, fast breathing (60bpm or less), severe chest in-drawing
or grunting, pus draining from umbilicus/multiple skin pustules.
Exclusion criteria:
Neonate with confirmed intrauterine viral infection (toxoplasmosis, cytomegalovirus, syphilis,
and herpes), neonates with visible congenital anomalies and inborn errors of metabolism
detected by new born screening were excluded from the study.
Study plan:
Neonates recruited for the study were grouped into suspected sepsis and age, location, and
gestational matched healthy controls. Baseline investigations such as complete blood count
(CBC), CRP, and blood culture and sensitivity were done for each neonate under the study as
a regular new born sepsis screening program. Positive cases were isolated from suspected cases
based on positive blood culture and sensitivity reports. DNA was extracted from EDTA whole
blood that was collected as a part of baseline hematological examination.
1. Blood genomic DNA extraction: The extraction was done by the non-enzymatic salting-out
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method adopted from Suguna et al. (21). About 200μl of EDTA blood was subjected for RBCs
lysis using TKM1 low salt buffer for 3 times followed by the lysis of cellular pellet using high
salt TKM2 buffer along with 10% sodium dodecyl sulfate (SDS). Lysis was done at 370C in a
shaker incubator. Further, the lysate was treated with 10μl of RNase A and incubated at room
temperature followed by centrifugation at 8000rpm for 5minutes. The supernatant was
transferred to a new 1.5ml microcentrifuge tube and an equal volume of isopropanol was added
and mixed gently by finger flicking. The sample mixture was incubated at -200C for 1 hour
followed by centrifugation at high speed (14000 rpm for 15minutes) under cold conditions
(40C). The supernatant was discarded and DNA precipitate at the bottom of the tube was
washed 2 times with 70% ice-cold ethanol. Finally, excess alcohol was drained off and the
precipitate was air-dried and then dissolved in 80μl of 1X-TE Buffer which was stored at -200C
for further use.
2. DNA Quantification and Purity assessment: The isolated DNA was quantified using
nanodrop (DeNovix). Absorbance at 260nm was recorded along with purity ratios
A260/280nm and A260/230 against blank i.e. 1X-TE. Concentrations of each DNA sample
(ng/μl) were also recorded.
3. DNA separation by Agarose Gel Electrophoresis: Blood genomic DNA was checked for
their intactness and quality by gel electrophoresis in which 1μg of DNA was subjected for
electrophoresis using 1.5% agarose gel. 1X-TAE Buffer with pH 8.2 was used to prepare
agarose gel as well as for running buffer. About 4μl of Ethidium bromide (10mg/ml) was used
as an intercalating dye for 100ml of melted agarose gel before casting into the gel tray with
appropriate combs. Casted agarose gel was allowed to polymerize at room temperature for 30
minutes and combs were removed along with sealers and then submerged into the 1X-TAE
running buffer present in the electrophoresis tank. DNA was mixed with 1X bromophenol blue
loading dye or tracking dye along with 1X-TE buffer as a sample diluent. DNA-dye mixture
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was loaded into the sample wells in an equal volume having equal concentrations of DNA.
Electrophoresis was carried out for 1 hour at 50V using a power pack. After electrophoresis,
the processed gel was exposed to UV-light using a gel documentation unit and DNA bands
were observed. The quality of DNA bands was analyzed for any degradation or solvent
contaminations that possess inhibiting properties in downstream applications.
4. Bisulfite conversion of DNA: After quantification and purity assessment of genomic DNA,
the same was subjected to bisulfite conversion by a manual method in which 2μg of DNA was
used from each of the DNA samples (22). In brief, 2μg of genomic DNA was mixed with 8.84
μl of bisulfite lysis buffer in the total volume of 18 μl and incubated at 370C in a water bath for
1 hour followed by the alkaline denaturation of DNA by adding 2 μl of 3M NaOH. The alkaline
denaturation was carried out at 370C for 15 minutes after which DNA was incubated at 900C
for 2 minutes using a dry block. The denaturation process was then stopped by immediately
shifting it over ice where it was incubated for 5 minutes. The sample was then centrifuged and
then subjected to bisulfite deamination by adding 208 μl of saturated metabisulphite along with
12 μl of 10mM quinol. The reaction mixture was mixed gently by inversion and centrifuged to
make the contents settle down to the bottom of the tube which was then overlaid with 100 μl
of mineral oil and incubated at 550C in a shaker incubator for 8 hours. The tubes were covered
with aluminium foil to avoid photo-oxidation after which the DNA bisulfite sample mixtures
were allowed to pass through the silica column to remove salts. The column was then washed
with washing buffer and the treated DNA was eluted in 50 μl of preheated molecular biology
grade water. The DNA elute was further mixed with 5.5 μl of 3M NaOH for desulfonation. The
content was incubated at 370C for 15 minutes followed by the addition of 1 μl of glycogen
(10mg/ml). About 10M ammonium acetate was added to the reaction mixture in a final
concentration of 3M and incubated at -800C for 1 hour. The reaction tubes were then cold
centrifuged at 14000 rpm for 15 minutes. The supernatant was removed, and the precipitate
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was washed with 70% ethanol. Finally, it was airdried and then dissolved in 0.1 TE buffer
(10mM Trsi-HCL, 0.1mM EDTA, pH 8.0) and incubated at -200C for 1 hour to completely
dissolve the bisulfite-converted DNA. The bisulfite converted DNA was again quantified using
nanodrop and 30 ng of it was used for methylation-specific PCR (MS-PCR).
5. Methylation-specific PCR for CALCA gene: MS-PCR was performed on thermal cycler
gradient (Takara) using the standard protocol. MS-PCR is a sensitive technique that utilizes
primers for CALCA gene methylation as well as unmethylation which anneals with the
corresponding complementary sequences present in the bisulfite-treated DNA. MSP can
distinguish methylated from unmethylated DNA after bisulfite modifications taking advantage
of the changes in the sequences due to treatment with bisulfite as originally reported by Herman
et

al

(23).

The

primers

that

amplify

unmethylated

(F-5’-

GTTTTGGAAGTATGAGGGTGACG-3’ & R-5’- TTCCCGCCGCTATAAATCG-3’- 105bp
amplicon size) and methylated (F-5’-TTTTAGGTTTTGGAAGTATGAGGGTGATG-3’ & R5’-TTCCCACCACTATAAATCA-3’- 100bp amplicon size) sequences of CALCA promoter
were synthesized by GeNoRime, based on Paixao et al (24). MS-PCR was carried out using an
optimized concentration of the reagents at a final concentration of 1X-EpiMark Hot start Taq
reaction buffer, 1U EpiMark Hot start Taq DNA polymerase, 0.2μM of each forward and
reverse primer sets, PCR enhancer, 0.2mM dNTPs mix in the final volume of 20 μl. About 1
μl (30 ng) of bisulfite-converted DNA was included in each of the reactions. PCR reaction was
carried out under the following condition that included, initial denaturation 950C for 5 minutes,
3 steps cycling for 30 cycles included denaturation 950C for 45 secs, annealing 570C for 45
secs and extension 720C for 45 secs followed by a final extension at 720C for 5 minutes with a
final hold at 40C. PCR amplified products were then subjected to electrophoresis using 2.5%
agarose using an isolated power supply of 50V for 90 minutes. DNA 100bp marker was also
included in the wells to estimate the sizes.
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6. EpiTect HRM analysis: High-resolution melting (HRM) analysis was utilized to study the
melting properties of both methylated as well as unmethylated products. Methylated samples
after PCR were subjected to HRM to establish the melting pattern of control. EpiTech HRM
kit (Qiagen) and the above-mentioned primers were used for HRM. About 20ng of bisulfite
converted DNA was taken as a template in each PCR reaction. HRM was carried out in RotorGene Q-5PLEX HRM–Qiagen under the following reaction conditions, initial denaturation:
950C for 5 minutes, 3 steps of preamplification phase for 35 cycles included denaturation: 950C
for 10 secs, annealing: 560C for 30 secs, extension: 720C for 15secs followed by HRM analysis
in which amplicons were melted from 600C to 900C in higher resolution mode with 0.10C
increment in temperature.
Statistical analysis
Epi info version 7.2 was used for all statistical analyses. The difference between mean
biochemical parameters between the two groups was assessed by inferential statistical tests like
unpaired t-test. Descriptive statistical measures were used to represent data as percentages or
mean and standard deviation. The differences were considered statistically significant at P<
0.05. Tables and figures are used to present the data wherever necessary.
Results:
A total of 115 neonates were included in the study out of which 63 were normal healthy controls
and 52 were diagnosed to have sepsis by the neonatologist based on the clinical presentation.
Out of the 52 neonates suspected to have sepsis only 7 had positive blood culture. The mean
age of the controls was 5.0±8.1 days and the mean age of the cases was 12.0±11.0 days. Both
the groups had more males, 41 in controls and 40 in cases. There was no significant difference
between the birth weight and gestational age of the neonates in the two groups. Among the
cases, 46 neonates improved whereas 3 neonates expired and 3 more were discharged against
medical advice. The clinical characteristics of the study subjects are shown in Table 1.
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Table 1: The clinical characteristics of the study subjects
Study parameters

Controls (n=63)

Cases (52)

P-value

Age (days)

5.0±8.1

12.0±11.0

0.000

Sex (F/M)

22/41

12/40

Birth weight (grams)

2332±733

2285±791

0.740

Gestation (weeks)

35.7±2.7

34.6±3.5

0.074

EOS/LOS

0

18/34

Proven sepsis (Culture +/-)

0

7/45

Outcome (Survived/expired)

62/1

46/3
(3

more

discharged

were
against

medical advice)
DNA methylation CALCA gene 62/1

47/5

(-/+)

The genomic DNA extraction from neonatal whole blood adopting the non-enzymatic saltingout method revealed good purity DNA having an average purity ratio of 1.75 (A260/280 ratio)
and 2.71 (A260/230) which is an ideal ratio for the bisulfite treatment (figure 1A). Bisulfite
treatment although resulted in the loss of DNA the purity of DNA was not compromised and
purity ratios were within the acceptable limit as shown in figure 1B. During bisulfite conversion
of DNA, almost 70 to 80% of DNA was lost, apart from this no major changes were observed
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in terms of purity as shown in figure 1B for a representative sample. The genomic DNA was
then subjected to 1.5% agarose gel electrophoresis and the quality of DNA was found to be
good with the intact band and no signs of DNA degradation were observed in the native form
as shown in figure 1C.

A.

B.

C.
Figure 1: A) Genomic DNA-Quantification and purity assessment by nanodrop (Sample:
13). B) Bisulfite treated DNA-Quantification and purity assessment by nanodrop
(Sample: 13BS). C) Left side: Genomic DNA bands (13S and 38N) Right side: Bisulfite
treated DNA bands (13-BS and 38-BS)
The amplification product of MS-PCR for methylated and unmethylated DNA was resolved by
using 2.5% agarose gel electrophoresis. Methylated DNA was separated and resolved at 100bp
whereas unmethylated DNA at 105bp is shown in figure 2 for a representative sample of 13bs.
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DNA methylation of the CALCA gene was detected in one healthy control and 5 neonates in
the sepsis group.

Figure 2: Methylation-specific PCR amplified bands for Unmethylated DNA (UM-105bp)
and Methylated DNA (M-100bp) along with Negative Control (NC) and Internal controls
(GAPDH-227bp). L – 100bp DNA marker. A representative image of samples (UM- 3BS
and M-113BS)
EpiTect HRM was performed for positive samples using EpiTech HRM kit (Qiagen) which
was carried out in Rotor-Gene Q-5PLEX HRM–Qiagen. Differences in the melting pattern
were indicated between methylated and unmethylated DNA and are shown in figure 3.
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Figure 3: EpiTect HRM- Melting pattern of methylated (M) and unmethylated (UM) DNAA representative image of samples (UM- 3BS and M-113BS).

Discussion:
DNA methylation is considered as a non-genetic change in which only the gene expression
changes due to methylation without any changes in the sequence of the gene at a particular
locus of the chromosome, usually CpG Island. CALCA promoter region is more prone for
methylation in several disease conditions including neonatal sepsis but DNA methylation as a
biomarker for neonatal sepsis has not been extensively studied. It is a specific feature of the
CALCA gene and studies have shown that other genes activated during sepsis did not show any
DNA methylation changes in their promoter region (26). Tendl et al. tried to evaluate the DNA
methylation status of the CALCA gene in the preterm neonates and 4 novel changes were
identified. 1. partial methylation at -769 CpG in 5 EOS, and 3 LOS cases; 2. demethylation of
8 CpGs in 1 EOS case; 3. demethylation of 7 CpGs in 2 EOS cases and; 4. -771 C:G>T:A; 5′
de novo -778 CpG mutation on both alleles in 1 EOS case. None of the controls showed any of
the above-described methylation changes. In neonatal sepsis, immunosuppression is the major
clinical manifestation due to incomplete maturation of immune cells especially among preterm
infants which predisposes to several abnormalities that have been found extended to the level
of gene expression. This study was taken up to find the occurrence of DNA methylation in the
promoter region of the CALCA gene among neonatal sepsis in a tertiary care hospital of South
India. The differences in genomic DNA methylation among cases and controls were observed
and this change in genomic DNA methylation level could be due to microbial infection which
is evident from the previous studies where the effect of Lipopolysaccharides (LPS) on DNA
methylation has been described. (25) The pathophysiology of sepsis in an individual not only
depends on the pathogen causing the infection but also on the genetic and epigenetic
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background of the host. During sepsis, there is a lot of burden on the immune system which
affects the functioning of the myeloid cells, and effects on epigenetic signatures in these cells
are seen. This leads to the differentiation and maturation of the immune cells with key changes
in their genes. The mortality in sepsis may be due to hyper-inflammation which leads to
immune paralysis or immunosuppression. Several studies have shown epigenetics to be a
driving force involved in short-term and long-term immunosuppression. (26) Hence, epigenetic
therapy might control the immune response and produce important effects on the host immune
system that may prove to be beneficial during the septic episode. Diet-induced epigenetic
modifications have also been observed in sepsis cases due to poor nutritional support to the
mother during her gestational period which could be a possible predisposing factor for earlyonset sepsis, but further studies are needed to support nutrigenomics in correlation with DNA
methylation. The study carried out on preterm infants having epigenetic changes in the CALCA
gene promoter region has proposed the need to explore whether DNA methylation changes
represent a cause or consequence of preterm birth which has been proved as one of the factors
predisposing to sepsis among new-borns.
Limitation of the study is that we have not confirmed the presence or absence of the DNA
methylation changes in the CALCA gene by sequencing. We have also not compared the DNA
methylation status with the serum PCT levels or with the type of bacteria affecting the neonates.
Conclusion:
The study was carried out to identify the occurrence of methylation in the CpG dinucleotide
promoter region of the CALCA gene using MS-PCR. The number of sepsis neonates reported
with DNA methylation in the promoter region of the CALCA gene were more when compared
to that of normal healthy controls. Hence, this may serve as a useful biomarker of sepsis in the
future. Further, we would like to study the changes in the DNA methylation status at different
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time points during the course of hospitalization to understand if it could prove to be useful in
assessing the prognosis for better management of sepsis.
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